Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 20, 2024 11:57am
RE:Pfizer appoints chief oncology officer as new CSO
Pfizer’s Oncology R&D organization will maintain its fully integrated structure with Roger Dansey, M.D. serving as Interim Chief Oncology Officer, reporting to Dr. Boshoff effective January 1
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Post by
Noteable
on Nov 20, 2024 11:45am
Pfizer appoints chief oncology officer as new CSO
November 20, 2024 - Chris Boshoff will take over the role of chief scientific officer and president of research and development as of January 1, 2025. He rises from his position as chief oncology
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(78)
•••
venture009
X
View Profile
View Bullboard History
Comment by
venture009
on Nov 20, 2024 11:43am
RE:My thanks , philosophical thoughts
"Why would anyone devote time and energy........" Hopefully so anyone reading would avoid the same fate all we long term investors have had, massive losses. There has been nothing but
...more
(206)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 19, 2024 8:30pm
RE:RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
We are so happy for your thoughts canuckcluck but we really don't care what you think. But you do have your nose so far up unnoteable's ace it's funny. The dissertation looked nice
...more
(931)
•••
canadafan
X
View Profile
View Bullboard History
Post by
canadafan
on Nov 19, 2024 6:09pm
My thanks , philosophical thoughts
My thanks to notable. In a tough environment of FUDsters, you keep updating important information. keeping in mind the best & most accurate & reliable source of information is the oncolytics
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 19, 2024 3:30pm
RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
To clarify even further, a confirmatory trial is run AFTER the FDA grants an ACCELERATED APPROVAL, which happens on the surrogate endpoints achieved in a Phase 2 clinical trial.
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 19, 2024 3:27pm
RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
ONCY has reported positive final results on the chosen surrogate endpoint of PFS and mOS, and therefore there are no apparent FDA restrictions on ONCY's ability to apply for an Accelerated
...more
(206)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 19, 2024 3:18pm
RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
Ole unnoteable et al has been spewing their garbage for years and i don't think it has changed what the company is doing one bit. Just like the liberals with their woke ideas. Put down
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 19, 2024 2:52pm
RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
Total nonsense Quentin30 ,,, but that is not uncommon coming from you.
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 19, 2024 2:51pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
First Merck acquires Incyte .. then comes ONCY. https://x.com/MarkKleinmanSky/status/1858942117827018868
(94)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Nov 19, 2024 2:50pm
RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
accelerated approval IS conditional itntdf...!! It grants marketing authorisation for 1 year... whilst a an ongoing study is conducted. The 180 patient data will still be needed to support
...more
(94)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Nov 19, 2024 2:45pm
RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
Not even the restrictions outlined by Professor Heineken..? Like the FACT they need 18 months to recruit and treat 180 patients, and 6 months of follow up to gather statisically relevant data for
...more
(1178)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Nov 19, 2024 2:43pm
RE:RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
Looks like Merck are trying to buy Incyte! Might answer some questions we've had.
(112)
•••
spesestsemper
X
View Profile
View Bullboard History
Post by
spesestsemper
on Nov 19, 2024 2:07pm
aio
AIO-KRK-0320ass_s.pdf
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden